PE and VC transactions turn on two numbers: the valuation at which primary equity is issued, and the relative value of the preferred instruments the investor receives. Getting either wrong costs the company either dilution it should not have given, or term-sheet protections it cannot defend at exit. Transique prepares independent pre-money and post-money valuations, preferred-versus-common analyses, ESOP valuations and pre-IPO cross-over valuations that stand up to investor-committee scrutiny and auditor review.
Our PE and VC valuations are prepared under the International Valuation Standards, and — for companies preparing for an IPO — in alignment with SEBI ICDR pricing frameworks and Ind AS 113 fair-value measurement principles.
No. Rule 11UA under the Income-Tax Rules has a prescribed methodology for unquoted equity shares (the NAV method or the DCF method, depending on facts). A PE / VC transaction-context valuation may be more flexible in methodology. Where a single report must serve both purposes, we scope accordingly at the engagement letter stage.
Transique Valuation Advisors is an IBBI-Registered Valuer Entity for Securities or Financial Assets. Where Section 56(2)(viib) of the Income-Tax Act is the governing provision (for Non Residents), a SEBI-registered merchant-banker co-signature is arranged as required.
Yes. Full-ratchet, broad-base and narrow-base weighted-average formulas are each modelled through OPM with the relevant ratchet triggers stress-tested in scenario analysis.
ESOP valuations are typically prepared on a fair-market-value basis of the underlying equity (or fair value of the option itself under Ind AS 102 / IFRS 2 for accounting purposes). The reference period, discount for lack of marketability, and control-premium considerations differ materially from transaction-context work.